Delivery Order SPE2DR25D1017-SPE2DR26F9CZZ
- Not listed
- The Defense Logistics Agency awarded a $40,234.19 delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams), with an ultimate completion date of December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,897.70 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with a completion date of January 8, 2026, awarded on January 7, 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.26 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price contract, issued on October 31, 2025, with completion by November 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $7,259.10 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This is a firm fixed price, non-set-aside contract with a completion date of December 31, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $7,612.67 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in a 60-gram unit. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical procurement supporting federal medical supply chain operations. The award was made on a non-set-aside, competitive basis to AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a $6,139.48 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price, non-set-aside contract with a completion date of September 16, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $17,181.12 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $45,518.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams), with an ultimate completion date of November 25, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CZZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,459.47 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% cream in 60-gram units. This competitive award, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, is structured as a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds significant contract vehicles with the Defense Logistics Agency that enable the supply of a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities and other federal medical institutions worldwide. This particular delivery order for Opzelura, a topical dermatological treatment, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the broader federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 1/11/26 |